Jeff Shuren Talks Breakthrough Bonanza, TPLC And Innovating Safety

In an interview at The MedTech Conference in Philadelphia this week, US FDA device-center Director Jeff Shuren spoke to Medtech Insight about what is happening with the pending total product lifecycle office and the larger-than-expected response to the Breakthrough Devices Program. He also makes the point that supporting innovation and protecting safety are not opposing goals, and more.